Calcineurin inhibitor immunosuppressive drugs induce changes such as arteriolar hyalinosis (ah) in kidney transplants, raising the possibility that molecular changes in biopsies related to histologic ah can provide information about drug exposure. We hypothesized that molecular changes associated with less-than-expected hyalino- 
of ah lesions vary with time of biopsy posttransplant (TxBx) 11 : in early biopsies, donor age; in late biopsies (>3 years), chronic glomerular diseases such as antibody-mediated rejection (ABMR) and glomerulonephritis (GN). At intermediate times (3 months to 3 years posttransplant) ah lesions had few associations, perhaps due to heterogeneity in the large ah0 group. High ah lesion scores are associated with graft loss, 11, 22 but this risk is not driven by ah lesions per se but by their association with chronic glomerular disease. 11 After correcting for TxBx, the risk for graft loss was higher in biopsies with ah0. Lack of ah lesions (ah0) at intermediate times was associated with increased risk of T cell-mediated rejection (TCMR). 11 However, histologic ah0
per se did not predict TCMR risk: most biopsies with ah0 did not have TCMR or borderline rejection. This may reflect inadequate granularity and precision in the histologic scoring system that cannot distinguish the many ah0 indication biopsies that are safe from those that have an increased risk of rejection potentially triggered by recent nonadherence. The present study explored whether the molecular changes associated with less-than-expected hyalinosis, corrected for TxBx, could help dissect the complexity in ah lesion associations, particularly in the intermediate period. We hypothesized that the molecular changes associated with ah when corrected for TxBx could be used as a probe for immunosuppressive drug underexposure, particularly for detection of nonadherence. Molecular changes associated with time-dependent lesions can be studied by controlling for TxBx. 23 The logic is that under-hyalinosis is sometimes associated with recent nonadherence;
therefore the molecules associated with under-hyalinosis may be associated with recent nonadherence, and may be particularly useful for flagging increased probability of recent nonadherence within the large number of ah0 biopsies. Note that the purpose was not to predict the presence of ah lesions, but to find a molecular method for predicting the nonadherence that is associated with less-than-expected ah lesions at intermediate times posttransplant. Although there is no criterion standard definition of nonadherence, we used a previously published definition of nonadherence: suspicion of nonadherence as recorded in the medical record. 24 
| MATERIALS AND METHODS

| Patient population, specimens, and data collection
Details of the patient cohort used for this analysis have been published. 11 Kidney transplant biopsies (n = 703) were collected in 2 consecutive prospective multicenter studies of 562 consented patients: 403 biopsies from the Genome Canada study and 300 from INTERCOM (ClinicalTrials.gov NCT01299168). [25] [26] [27] [28] Patients were consented under protocols approved by local institutional review boards and were included if they had biopsies suitable for histology reporting and microarray analysis. For patients who had >1 biopsy during the study period (n = 102), we randomly selected 1 biopsy, resulting in 562 biopsies used for this study.
Almost all patients (96%) were recorded as being on CNIs at some time, and 92% were on CNIs at the time of biopsy. As a multicentered cross-sectional study that included patients up to 35 years posttransplant, detailed CNI exposure was either unavailable, or uninterpretable.
Information on adherence was available only for a subset of patients (263/562). Nonadherence was defined based on medical records of patient admission or strong clinical suspicion by the attending clinicians, independent of the study. Based on that definition, nonadherence was recorded at the time of biopsy in 20 patients, and 249 patients were classified as adherent at the time of biopsy.
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| Conventional biopsy assessment
Details of conventional biopsy assessment have been published. [25] [26] [27] [28] Biopsy processing was performed as standard of care for the center.
The biopsies were assessed by local pathologists. Histologic diagnosis followed the Banff system. 18,29 Subgroups of ABMR were assigned according to the presence of lesions: pgABMR = ABMR with glomerulitis (g) or peritubular capillaritis (ptc) but no cg lesions; cgABMR = ABMR with cg lesions but no g or ptc lesions; pgcgABMR = ABMR with (g or ptc) and cg lesions.
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HLA antibody testing at biopsy was recommended in the study but was determined by local standard of care. Antibody specificities were usually determined either by LABScreen ® or FlowPRA ® single antigen beads (One Lambda, Canoga Park, CA). No testing was reported for 75, and donor-specific antibody was not reported in 11 PRA-positive patients.
| Microarray analyses
One extra biopsy core or a portion thereof was collected for microarray analysis, placed immediately in RNALater (Ambion, Inc., Naugatuck, CT) kept at 4°C for 4-24 hours, and stored at −20°C. RNA extraction, labeling, and processing of HG_U133_Plus_2.0 GeneChips (Affymetrix, Santa Clara, CA) were described previously [25] [26] [27] [28] 31 (www.affymetrix. com). Microarray files were analyzed using the "R" software package 
| Classifier construction and cross-validation
The molecular classifier was built using linear discriminant analysis implemented in the "lda" function of "R," with scores assigned using 10-fold cross-validation. The 562 samples were split randomly into 10 approximately equally sized groups (folds), with 1 fold left out as a test set and 9 used as the training set. 25, 34 The training set was used to predict the presence of arteriolar hyalinosis (ah > 0) with continuous values between 0.0 and 1.0. This procedure was applied to all 10 folds, resulting in a single predicted score for each of the 562 biopsies. This process was then repeated a further 49 times, using different random splits into 10 folds, so that every biopsy was assigned 50 M ah -scores. The median of the 50 scores for each biopsy was the final score.
In each fold of the cross-validation, the R package "limma" was used to rank, by P value, the probe sets after "controlling" for log 10 (TxBx), ie by including log 10 (TxBx) as a covariate in gene selection. The top 19
probe sets, along with log 10 (TxBx), were used as predictors. By controlling for TxBx, our aim was to find molecular signals independent of time. No test set information was ever allowed into the gene selection process, which was based solely on training set samples.
| Other molecular measurements
We used the following previously defined gene sets and classifiers 
| Statistics
Data analyses were performed using R software (see above). Spearman 
| RESULTS
| Demographics
The population demographics, the distribution of the hyalinosis lesions and their associations with histologic lesions, diagnoses, and clinical features were previously published. 11 Almost all patients (96%)
were recorded as being on CNIs at some time, and 92% were on CNIs at the time of biopsy.
| Molecular associations of ah lesions
There was no strong correlation between histologic ah lesions and previously defined transcript sets representing biological events: (r = −.11), or ABMR (r = .17). After correcting for TxBx using a linear model, the major finding was a strong negative correlation between ah lesions and the molecular TCMR score (r = −.58, P = .003), ie low ah lesions were associated with molecular TCMR.
| Building a molecular classifier to detect ah lesions
To explore the associations between gene expression and ah lesions, we built a molecular classifier, the M ah -score, trained on ah lesions (ah0 vs ah > 0) after correcting for TxBx (see Materials and Methods). The purpose was to use molecules to predict the conditions associated with less-than-expected hyalinosis. The list of the top 19 probe sets using the full data set (Table S1) 
| Relationship of M ah to TxBx and histologic ah
The M ah -score correlated strongly with TxBx (r = .86, P < .0001) but did not behave like the histologic ah-score. Figure 1 shows the moving averages of ah-scores and M ah over time posttransplant. As reported, 11 the mean histology ah-scores increased with log(TxBx), but only after a prolonged lag period of >2 years, during which they did not increase. In contrast, the mean molecular M ah -score increased linearly with log (TxBx).
As expected, M ah correlated with histology ah-scores (r = .50, P < .0001). Biopsies with ah3 almost all had high M ah -scores. However, within the other histology ah-categories, there was great variation in M ah , particularly within the large group of biopsies with no hyalinosis (ah0) (Figure 2 ).
| Relationship of M ah to histologic lesions and gene sets
We studied the relationship of M ah to clinical features, histologic lesions, and previously defined gene sets. As expected, M ah correlated with ah lesions and TxBx. The other main positive correlations of M ah were with scarring and chronic glomerular lesions (Table S2 ). There was a moderate negative correlation with lesions of TCMR and a stronger negative correlation with gene sets reflecting injury and T cell infiltration and with the molecular TCMR score. These relationships were largely retained when assessing only biopsies with histologic ah0. The negative relationship with injury, inflammation, and TCMR scores was stronger within biopsies with ah0.
| Relationship of M ah to histologic diagnosis and TxBx
We visualized the M ah -score for all 562 biopsies individually vs their TxBx, coloring the biopsies by their histologic diagnoses ( Figure 3A ).
Almost all biopsies with TxBx >5 years had high M ah -scores; most of these had ABMR, GN, or unexplained atrophy-fibrosis. 
| Calculating the hyalinosis index to assess the significance of deviation from the regression line
Given that the M ah -score uses genes and TxBx as predictors, deviations from the regression line with TxBx are caused primarily by the The relationships between hyalinosis index, diagnoses, and nonadherence as defined by clinician suspicion in the medical record are illustrated as moving averages in Figure 5C . The prevalence of TCMR, pgABMR, and nonadherence is highest in biopsies with low a hyalinosis index and decreases with a normal or high hyalinosis index. In 
| Association of the hyalinosis index scores with graft loss
Overall, most graft loss occurred in patients with normal/high hyalinosis index. However, considering the number of patients at risk, relative graft loss was highest in biopsies with a low hyalinosis index and decreased continuously with increasing hyalinosis indices ( Figure 5C ).
This association was significant in a univariate analysis (P = 4.9E-06).
The association of a low molecular hyalinosis index with graft loss was independent of the presence of histologic ah lesions: a low index was associated with increased graft loss in all grafts ( Figure 6A ); in grafts with no histologic hyalinosis (P = .007) ( Figure 6B) ; and in grafts with histologic hyalinosis (P = .04) ( Figure 6C ).
In summary, a low hyalinosis index is common in biopsies at intermediate times posttransplant and is associated with rejection (TCMR and early-stage ABMR) and with an increased probability of physicianrecorded concerns about nonadherence, and identifies a subgroup of patients at high risk for graft loss, particularly those with pgABMR. In the subset with medical records available for review, a low hyalinosis index was associated with increased recorded concerns about nonadherence.
| DISCUSSION
We used arteriolar hyalinosis as a probe for immunosuppressive drug exposure with a particular interest in potential underexposure due to The weak association of the hyalinosis index with ABMR molecular features overall is because only a minority of ABMR presenting in indication biopsies is associated with nonadherence at the time of biopsy.
The natural history of nonadherence may be initial TCMR evolving to ABMR, which determines the fate of the graft.
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Principal limitations of this analysis are those imposed by a study using biopsies with TxBx distributed over decades, which precludes capturing detailed drug exposure and intercurrent events. More granular information about CNI levels, diabetes, and hypertension would improve our ability to interpret hyalinosis and distinguish molecular features, but capturing and interpreting such information in outpatients years or decades after transplantation is impossible within a multicenter study that is not dedicated to drug history per se. Total Nonadherence is difficult to study, due to lack of reliable detection tools and patient reluctance to admit nonadherence, and there is no accepted standard definition. 44 In our study, nonadherence was defined based on chart review in a subpopulation to identify either strong suspicion by the treating physician or patient admittance. The . Graft loss in these groups was assessed across all biopsies (n = 562) (A), biopsies with no histologic hyalinosis (ah lesion score = 0) (n = 225) (B), and biopsies with histologic hyalinosis (ah lesion score > 0) (n = 304) (C). In 34 biopsies the ah lesion could not be assessed by histology; these biopsies were excluded from the analysis in (B) and (C). Bx, biopsy biopsy is highly time dependent, and these new indices take this time risk into account. We hypothesize that a low molecular hyalinosis index detects the risk for rejection due to nonadherence: TCMR and some early-stage ABMR. The principle of the association of molecular rejection with under-hyalinosis has been validated in a new study, where archetypal analysis identified a cluster of biopsies with a severe TCMR (often with early ABMR) phenotype with under-hyalinosis. 45 The same information cannot currently be inferred from an ah0 lesion score because there is simply too little granularity in the current ah0,1,2,3 grades, and they have limited reproducibility. These results illustrate the power of molecular methods and machine learning to find unexpected and clinically relevant relationships that are obscured by the noise in conventional features. 
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